Increasing Uptake of Bowel Screening

NCT ID: NCT05408169

Last Updated: 2023-12-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40000 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-06-20

Study Completion Date

2023-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Bowel cancer is the second biggest cancer killer in the UK, accounting for over 16,000 deaths per year. Screening can reduce deaths from bowel cancer if the people invited participate. The challenge is that high uptake of bowel screening is hard to achieve, and remains persistently below 65%.

The faecal immunochemical test (FIT) is the most widely used bowel screening test worldwide.

In the UK, FIT kits are mailed to people's homes without guidance on when the kit should be returned and only brief instruction on how to use it. Some people have said that even though they intend to complete and return the kit, they often forget or put off doing it.

Two approaches are proposed to addressing this issue: i) providing a suggested deadline for FIT return, because it is known from breast and cervical cancer screening that giving people an appointment time increases uptake compared to an open invitation, and ii) planning sheets, that have been found to help people act on their intentions in other health contexts.

This trial aims to evaluate the impact of providing a suggested deadline and a planning sheet on the return of FIT bowel screening kits.

The trial is integrated within the Scottish Bowel Screening Programme. The investigators will randomly allocate 40,000 consecutive people that are due to be sent a FIT kit to one of eight groups:

(i) control group (no deadline, no planning sheet), (ii) intervention group (1-week deadline, no planning sheet), (iii) intervention group (2-week deadline, no planning sheet), (iv) intervention group (4-week deadline, no planning sheet), (v) intervention group (no deadline, with planning sheet), (vi) intervention group (1-week deadline, with planning sheet), (vii) intervention group (2-week deadline, with planning sheet), (viii) intervention group (4-week deadline, with planning sheet).

It will then be examined if having a suggested deadline and a planning sheet affects how many people send back their completed FIT kit. It will also be examined if the deadline length makes a difference and whether having both a deadline and a planning sheet affects the number of people returning their kit.

Finally, the cognitive and behavioural mechanisms underlying any intervention effects will be assessed and the acceptability of the interventions explored, using questionnaires and in-depth interviews.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colorectal Cancer

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Early Detection of Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

Group Type NO_INTERVENTION

No interventions assigned to this group

1-week deadline, no planning sheet

Group Type EXPERIMENTAL

Suggested deadline for return of screening test

Intervention Type BEHAVIORAL

A screening invitation letter modified to state, highlighted in yellow: "Please return your kit within \[X\] weeks (by \[DD.MM.YYYY\]) or as soon as possible."

2-week deadline, no planning sheet

Group Type EXPERIMENTAL

Suggested deadline for return of screening test

Intervention Type BEHAVIORAL

A screening invitation letter modified to state, highlighted in yellow: "Please return your kit within \[X\] weeks (by \[DD.MM.YYYY\]) or as soon as possible."

4-week deadline, no planning sheet

Group Type EXPERIMENTAL

Suggested deadline for return of screening test

Intervention Type BEHAVIORAL

A screening invitation letter modified to state, highlighted in yellow: "Please return your kit within \[X\] weeks (by \[DD.MM.YYYY\]) or as soon as possible."

No deadline, with planning sheet

Group Type EXPERIMENTAL

Planning sheet

Intervention Type BEHAVIORAL

A planning tool presented on a separate single sheet of paper inserted into the screening invitation envelope. The colour illustrated tool prompts participants to identify concerns they have with using the bowel screening kit and to link them to a tip to help them overcome this concern.

1-week deadline, with planning sheet

Group Type EXPERIMENTAL

Suggested deadline for return of screening test

Intervention Type BEHAVIORAL

A screening invitation letter modified to state, highlighted in yellow: "Please return your kit within \[X\] weeks (by \[DD.MM.YYYY\]) or as soon as possible."

Planning sheet

Intervention Type BEHAVIORAL

A planning tool presented on a separate single sheet of paper inserted into the screening invitation envelope. The colour illustrated tool prompts participants to identify concerns they have with using the bowel screening kit and to link them to a tip to help them overcome this concern.

2-week deadline, with planning sheet

Group Type EXPERIMENTAL

Suggested deadline for return of screening test

Intervention Type BEHAVIORAL

A screening invitation letter modified to state, highlighted in yellow: "Please return your kit within \[X\] weeks (by \[DD.MM.YYYY\]) or as soon as possible."

Planning sheet

Intervention Type BEHAVIORAL

A planning tool presented on a separate single sheet of paper inserted into the screening invitation envelope. The colour illustrated tool prompts participants to identify concerns they have with using the bowel screening kit and to link them to a tip to help them overcome this concern.

4-week deadline, with planning sheet

Group Type EXPERIMENTAL

Suggested deadline for return of screening test

Intervention Type BEHAVIORAL

A screening invitation letter modified to state, highlighted in yellow: "Please return your kit within \[X\] weeks (by \[DD.MM.YYYY\]) or as soon as possible."

Planning sheet

Intervention Type BEHAVIORAL

A planning tool presented on a separate single sheet of paper inserted into the screening invitation envelope. The colour illustrated tool prompts participants to identify concerns they have with using the bowel screening kit and to link them to a tip to help them overcome this concern.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Suggested deadline for return of screening test

A screening invitation letter modified to state, highlighted in yellow: "Please return your kit within \[X\] weeks (by \[DD.MM.YYYY\]) or as soon as possible."

Intervention Type BEHAVIORAL

Planning sheet

A planning tool presented on a separate single sheet of paper inserted into the screening invitation envelope. The colour illustrated tool prompts participants to identify concerns they have with using the bowel screening kit and to link them to a tip to help them overcome this concern.

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Volitional help sheet

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 50-74 years
* Registered with a Community Health Index number in Scotland
* More than 2 years since last bowel screening invitation

Exclusion Criteria

* Has self-excluded from Scottish Bowel Screening Programme
* Not sent a screening kit by the Scottish Bowel Screening Programme
Minimum Eligible Age

50 Years

Maximum Eligible Age

74 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

NHS Greater Glasgow and Clyde

OTHER

Sponsor Role collaborator

NHS Tayside

OTHER_GOV

Sponsor Role collaborator

University of Cambridge

OTHER

Sponsor Role collaborator

University of St Andrews

OTHER

Sponsor Role collaborator

University of Stirling

OTHER

Sponsor Role collaborator

University of Dundee

OTHER

Sponsor Role collaborator

Chief Scientist Office of the Scottish Government

OTHER_GOV

Sponsor Role collaborator

Cancer Research UK

OTHER

Sponsor Role collaborator

University of Glasgow

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Katie Robb

Professor of Behavioural Science and Health

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Katie Robb

Role: PRINCIPAL_INVESTIGATOR

University of Glasgow

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Scottish Bowel Screening Centre

Dundee, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Robb KA, Young B, Murphy MK, Duklas P, McConnachie A, Hollands GJ, McCowan C, Macdonald S, O'Carroll RE, O'Connor RC, Steele RJC. Behavioural interventions to increase uptake of FIT colorectal screening in Scotland (TEMPO): a nationwide, eight-arm, factorial, randomised controlled trial. Lancet. 2025 Mar 29;405(10484):1081-1092. doi: 10.1016/S0140-6736(24)02813-7. Epub 2025 Mar 12.

Reference Type DERIVED
PMID: 40088914 (View on PubMed)

Robb KA, Kotzur M, Young B, McCowan C, Hollands GJ, Irvine A, Macdonald S, McConnachie A, O'Carroll RE, O'Connor RC, Steele RJC. Increasing uptake of FIT colorectal screening: protocol for the TEMPO randomised controlled trial testing a suggested deadline and a planning tool. BMJ Open. 2023 May 18;13(5):e066136. doi: 10.1136/bmjopen-2022-066136.

Reference Type DERIVED
PMID: 37202130 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GN19GA165

Identifier Type: -

Identifier Source: org_study_id